Laman Utama500087 • BOM
add
Cipla Ltd
Tutup sebelumnya
₹1,465.65
Julat hari
₹1,455.85 - ₹1,496.20
Julat tahun
₹1,165.10 - ₹1,702.00
Permodalan pasaran
1.20T INR
Bilangan Purata
67.70K
Nisbah P/E
26.83
Hasil dividen
0.87%
Pertukaran utama
NSE
Berita pasaran
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (INR) | Sep 2024info | Perubahan T/T |
|---|---|---|
Hasil | 69.61B | 5.65% |
Perbelanjaan pengendalian | 30.64B | 8.19% |
Pendapatan bersih | 13.03B | 15.18% |
Margin untung bersih | 18.71 | 9.03% |
Pendapatan bagi setiap syer | 16.12 | 15.14% |
EBITDA | 18.73B | 9.64% |
Kadar cukai berkesan | 27.01% | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (INR) | Sep 2024info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | 87.08B | 78.06% |
Jumlah aset | 346.55B | 10.45% |
Jumlah liabiliti | 62.00B | -1.31% |
Jumlah ekuiti | 284.56B | — |
Syer tertunggak | 807.57J | — |
Harga kepada buku | 4.17 | — |
Pulangan pada aset | — | — |
Pulangan pada modal | 14.34% | — |
Aliran Tunai
Perubahan bersih dalam tunai
| (INR) | Sep 2024info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | 13.03B | 15.18% |
Tunai daripada operasi | — | — |
Tunai daripada pelaburan | — | — |
Tunai daripada pembiayaan | — | — |
Perubahan bersih dalam tunai | — | — |
Aliran tunai bebas | — | — |
Perihal
Cipla Limited is an Indian multinational pharmaceutical company headquartered in Mumbai. Cipla primarily focuses on developing medication to treat respiratory disease, cardiovascular disease, arthritis, diabetes, depression, paediatric and various other medical conditions. Cipla has 47 manufacturing locations across the world and sells its products in 86 countries. It is the third-largest drug producer in India. Wikipedia
CEO
Diasaskan
1935
Ibu pejabat
Tapak web
Pekerja
27,764
